ExOMIND, 非侵入性脑健康技术, 在印度启动 治疗抑郁症、焦虑症和认知下降 早期成功。 EXOMIND, a non-invasive brain health tech, launches in India to treat depression, anxiety, and cognitive decline with early success.

EXOMIND是一个新的非侵入性脑健康技术,已经在印度启动,标志着精神保健的显著进步。 EXOMIND, a new non-invasive brain health technology, has launched in India, marking a significant advancement in mental wellness. 该创新旨在通过安全、非外科的大脑刺激,改善认知功能和心理健康,为抑郁、焦虑和认知下降等状况提供有希望的替代办法。 The innovation aims to improve cognitive function and mental health through safe, non-surgical brain stimulation, offering a promising alternative for conditions like depression, anxiety, and cognitive decline. 早期试验显示出积极的成果,用户报告说重点更加突出、情绪稳定、精神清晰。 Early trials show positive results, with users reporting enhanced focus, mood stability, and mental clarity. 该倡议是扩大印度可获取精神保健的范围的更广泛努力的一部分,可影响全球精神保健战略。 The initiative is part of a broader effort to expand accessible mental health care in India and could influence global mental wellness strategies.